Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04486378
Title A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors BioNTech RNA Pharmaceuticals GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | GBR | ESP | DEU | BEL


No variant requirements are available.